Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

VX-497: selective IMPDH inhibitor with potent immunosuppressive properties

May 22, 1997

PNP inhibitors from Chiroscience for T-cell-mediated disorders

May 21, 1997

Wyeth-Ayerst and NanoSystems agree to develop new formulation of Rapamune

May 20, 1997

Roche and Protein Design Labs report encouraging results from Zenapax trial

May 20, 1997

Phase I/II results for promising compound from BioTransplant and MedImmune

May 20, 1997

BioChem Pharma subsidiary signs agreement to develop nasally delivered vaccines

May 14, 1997

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

May 9, 1997

Nippon Shinyaku prepares improved ciclosporin derivatives

May 9, 1997

Aquila's QS-21 enhances immune response of DNA vaccines in preclinical studies

May 9, 1997

Alexion issued two patents covering technology for xenotransplantation products

May 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...